Quality of antibiotic prescribing to children through the coronavirus disease 2019 (COVID-19) pandemic

• Published in: Antimicrobial stewardship & healthcare epidemiology : ASHE 2022, Vol.2 (1), p.e94-e94, Article e94
• Main Authors: Wattles, Bethany A, Jawad, Kahir S, Feygin, Yana F, Stahl, J Drew, Vidwan, Navjyot K, Stevenson, Michelle D, Kong, Maiying, Smith, Michael J
• Format: Article
• Language: English
• Subjects: Original
• ISSN: 2732-494X; 2732-494X
• DOI: 10.1017/ash.2022.235

To describe pediatric outpatient visits and antibiotic prescribing during the coronavirus disease 2019 (COVID-19) pandemic. An observational, retrospective control study from January 2019 to October 2021. Outpatient clinics, including 27 family medicine clinics, 27 pediatric clinics, and 26 urgent or prompt care clinics. Children aged 0-19 years receiving care in an outpatient setting. Data were extracted from the electronic health record. The COVID-19 era was defined as April 1, 2020, to October 31, 2021. Virtual visits were identified by coded encounter or visit type variables. Visit diagnoses were assigned using a 3-tier classification system based on appropriateness of antibiotic prescribing and a subanalysis of respiratory visits was performed to compare changes in the COVID-19 era compared to baseline. Through October 2021, we detected an overall sustained reduction of 18.2% in antibiotic prescribing to children. Disproportionate changes occurred in the percentages of antibiotic visits in respiratory visits for children by age, race or ethnicity, practice setting, and prescriber type. Virtual visits were minimal during the study period but did not result in higher rates of antibiotic visits or in-person follow-up visits. These findings suggest that reductions in antibiotic prescribing have been sustained despite increases in outpatient visits. However, additional studies are warranted to better understand disproportionate rates of antibiotic visits.